http://orcid.org/0000-0002-6513-5147
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Annibal Parracho Sant’Anna, Luiz Octávio Gavião & Tiago Lezan Sant’Anna. (2023) Multi-criteria classification of reward collaboration proposals. IISE Transactions 0:0, pages 1-11.
Read now
Read now
Baher Elezbawy, Ahmad Nader Fasseeh, Amal Sedrak, Randa Eldessouki, Mary Gamal, Mariam Eldebeiky, Hanaa Amer, Shimaa Akeel, Ahmad Morsy, Amira Amin, Amr Shafik, Sherif Abaza & Zoltán Kaló. (2022) A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt. Journal of Pharmaceutical Policy and Practice 15:1.
Read now
Read now
Anke-Peggy Holtorf, Erna Kristin, Anunchai Assamawakin, Nilawan Upakdee, Rina Indrianti & Napassorn Apinchonbancha. (2021) Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand. Journal of Pharmaceutical Policy and Practice 14:1.
Read now
Read now
Ali Hadi Abdullah, Anke-Peggy Holtorf, Maryam Al-Hussaini, Jacinthe Lemay, Maryam Alowayesh & Zoltán Kaló. (2019) Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait. Journal of Pharmaceutical Policy and Practice 12:1.
Read now
Read now
Articles from other publishers (17)
Gergely Németh, Mánuel László Mágó, Zoltán Kaló, Judit Lám, Tamás Balogh & Valentin Brodszky. (2023) A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply. Frontiers in Medicine 10.
Crossref
Crossref
R. Brett McQueen, Nicholas D. Mendola, Ivett Jakab, Jeffrey Bennett, Kavita V. Nair, Bertalan Németh, András Inotai & Zoltán Kaló. (2022) Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods. PharmacoEconomics - Open 7:2, pages 217-228.
Crossref
Crossref
Zsuzsanna Ida Petykó, Zoltán Kaló, Jaime Espin, Kateřina Podrazilová, Tomáš Tesař, Nikos Maniadakis, Frank-Ulrich Fricke & András Inotai. (2021) Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Crossref
Zoltán Kaló, Zsuzsanna Ida Petykó, Frank-Ulrich Fricke, Nikos Maniadakis, Tomáš Tesař, Kateřina Podrazilová, Jaime Espin & András Inotai. (2021) Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Crossref
Talita D. C. Frazão, Ana F. A. dos Santos, Deyse G. G. Camilo, João Florêncio da Costa Júnior & Ricardo P. de Souza. (2021) Priority setting in the Brazilian emergency medical service: a multi-criteria decision analysis (MCDA). BMC Medical Informatics and Decision Making 21:1.
Crossref
Crossref
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Crossref
Siobhan Botwright, Birgitte K. Giersing, Martin I. Meltzer, Anna-Lea Kahn, Mark Jit, Nathalie El Omeiri, Joseph N.-M. Biey, Kelly L. Moore, Praveen Thokala, Jason M. Mwenda, Melanie Bertram, Rob Baltussen & Raymond C.W. Hutubessy. (2021) The CAPACITI Decision-Support Tool for National Immunization Programs. Value in Health 24:8, pages 1150-1157.
Crossref
Crossref
András InotaiIvett JakabDiana BrixnerJonathan D CampbellNeil HawkinsLars Erik KristensenMata CharokopouIrina MountianBoglarka SzegvariZoltán Kaló. (2021) Proposal for capturing patient experience through extended value frameworks of health technologies. Journal of Managed Care & Specialty Pharmacy 27:7, pages 936-947.
Crossref
Crossref
Fatine Ezbakhe & Agustí Pérez-Foguet. (2021) Decision analysis for sustainable development: The case of renewable energy planning under uncertainty. European Journal of Operational Research 291:2, pages 601-613.
Crossref
Crossref
Yee Vern Yong, Siti Hajar Mahamad Dom, Nurulmaya Ahmad Sa’ad, Rosliza Lajis, Faridah Aryani Md. Yusof & Jamalul Azizi Abdul Rahaman. (2021) Development and Practical Application of a Multiple-Criteria Decision Analysis Framework on Respiratory Inhalers: Is It Always Useful in the MOH Malaysia Medicines Formulary Listing Context?. MDM Policy & Practice 6:1, pages 238146832199406.
Crossref
Crossref
Ivett Jakab, Bertalan Németh, Baher Elezbawy, Melis Almula Karadayı, Hakan Tozan, Sabahattin Aydın, Jie Shen & Zoltán Kaló. (2020) Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses. Frontiers in Pharmacology 11.
Crossref
Crossref
Rachel A. Archer, Ritika Kapoor, Wanrudee Isaranuwatchai, Yot Teerawattananon, Birgitte Giersing, Siobhan Botwright, Jos Luttjeboer & Raymond C. W. Hutubessy. (2020) ‘It takes two to tango’: Bridging the gap between country need and vaccine product innovation. PLOS ONE 15:6, pages e0233950.
Crossref
Crossref
Shanlian Hu, Anke-Peggy Holtorf, Kalman Wijaya, Jiangjiang He & Diana Brixner. 2020. Evaluation of Health Services. Evaluation of Health Services.
Anunchai Assawamakin, Anke-Peggy Holtorf & Nikolaos Maniadakis. 2020. Evaluation of Health Services. Evaluation of Health Services.
Bertalan Németh, Anett Molnár, Sándor Bozóki, Kalman Wijaya, András Inotai, Jonathan D Campbell & Zoltán Kaló. (2019) Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries. Journal of Comparative Effectiveness Research 8:4, pages 195-204.
Crossref
Crossref
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso GuerraJr.Jr., Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell & Alan Haycox. (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in Public Health 6.
Crossref
Crossref
Andras Inotai, Diana Brixner, Nikos Maniadakis, Iwan Dwiprahasto, Erna Kristin, Agus Prabowo, Alfi Yasmina, Sigit Priohutomo, Bertalan Németh, Kalman Wijaya & Zoltan Kalo. (2018) Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia. BMC Health Services Research 18:1.
Crossref
Crossref